Page last updated: 2024-11-02

oxybutynin and Tachycardia, Ventricular

oxybutynin has been researched along with Tachycardia, Ventricular in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
" Scopolamine is metabolized primarily in the liver and excreted by the kidneys, so renal and hepatic impairment should be considered when initiating and dosing this medication."1.42An unusual case of nonsustained ventricular tachycardia. ( Brandt, JC; Harman, E; Winchester, D, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, JC1
Harman, E1
Winchester, D1

Other Studies

1 other study available for oxybutynin and Tachycardia, Ventricular

ArticleYear
An unusual case of nonsustained ventricular tachycardia.
    Therapeutic advances in cardiovascular disease, 2015, Volume: 9, Issue:3

    Topics: Cholinergic Antagonists; Female; Humans; Middle Aged; Scopolamine; Tachycardia, Ventricular; Transde

2015